Kyowa Hakko Kirin Of Japan To Team With University For ATL Drug
This article was originally published in PharmAsia News
Japan's Kyowa Hakko Kirin reportedly plans to collaborate with Nagoya City University to develop a drug to treat adult T-cell leukemia
You may also be interested in...
The first major revision since 2007 notably provides a legal foundation for special approvals under a public health crisis.
Resolution Medical teamed up with Carbon to introduce more than one million 3D-printed nasal swabs a week to address the shortage for COVID-19 testing.
Early results from the Low-Risk Bicuspid study of the Evolut transcatheter aortic valve replacement system showed low rates of all-cause mortality or stroke.